title: Halofantrine-associated ventricular fibrillation in a young woman with no predisposing QTc prolongation.
authors.affiliation: Department of Infectious Diseases, Ullevaal Hospital, University of Oslo, Norway.
authors.forename: S G
authors.initials: SG
authors.lastname: Gundersen
authors.forename: M
authors.initials: M
authors.lastname: Rostrup
authors.forename: E
authors.initials: E
authors.lastname: von der Lippe
authors.forename: E S
authors.initials: ES
authors.lastname: Platou
authors.forename: B
authors.initials: B
authors.lastname: Myrvang
authors.forename: G
authors.initials: G
authors.lastname: Edwards
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D010616:Phenanthrenes / Q000009:adverse effects* / Q000097:blood; D014693:Ventricular Fibrillation / Q000139:chemically induced*
chemical_list: D000962:Antimalarials; D010616:Phenanthrenes; C044961:1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol; C023768:halofantrine